Nouscom, a clinical stage immuno-oncology company developing off-the-shelf and personalized viral vector-based cancer vaccines targeting neoantigens, has promoted Tiffany Muller to Chief Financial Officer and Loredana Siani, Ph.D., to Senior Vice President (SVP), Technical and CMC Development.

Ms. Muller joined Nouscom in 2019 as Vice President of Finance bringing close to 20 years of experience in finance, including global treasury, financial planning and analysis (FP&A), investments and investor relations. In 2023, she was promoted to Senior Vice President of Finance. Prior to joining Nouscom, she held various leadership roles at Aramark managing complex financial operations. 

Dr. Siani joined Nouscom as Technical Director in 2020 from Reithera, a CDMO, where she served as the GMP Manufacturing Head. Previously, she held the same role at Advent GMP Facility (now Advaxia Biologics). In these positions, Loredana was instrumental in getting CDMO manufacturing authorizations and successfully oversaw multiple production campaigns for viral vector products used in gene therapy and vaccines. 

Dr. Marina Udier, CEO of Nouscom, said, “Tiffany is a highly valued leader and strategic thought partner who has been instrumental to Nouscom’s recent successful oversubscribed series C financing and overall corporate development. We are thrilled to promote Tiffany to CFO at this pivotal time as we advance our clinical cancer vaccine portfolio to late-stage development. Her extensive experience and demonstrated capability, along with our robust financial standing, position Nouscom to accelerate its growth and build on the successes achieved to date.

“Simultaneously, Loredana will be stepping into the important role of Senior Vice President of Technical and CMC Development. With her extensive expertise and collaborative spirit, Loredana has been an integral part of our team, consistently exceeding expectations to ensure Nouscom’s success. Her ability to inspire others has made a significant positive impact on our team and will be crucial as we prepare for the next stage in the company’s growth.